Australian and British researchers have determined the structure of perforin, a protein which plays a part in helping insulin-producing beta cells get killed off by the body’s immune system in early onset diabetes (type 1 diabetes).
Perforin is a protein found in cytotoxic cells (cells which kill other cells). Two of the cells which carry the perforin protein are T cells and NK cells (natural killer cells). Perforin acts by opening up small holes in rogue cells allowing toxic enzymes to enter and kill those rogue cells.
Using electron microscopes, Australian and British scientists have discovered the structure of these proteins, helping to understand how these proteins are able to make holes in rogue cells. They found that the perforin molecules clustered together in a ring in order to open a hole in the target cells.
With a greater understanding now of how these cells work, it is hoped that perforin activity could be inhibited, in the early stages of type 1 diabetes, to slow down the body’s ability to kill off the cells in the pancreas which produce insulin .
However, it is not just type 1 diabetes that perforin plays a role within. If perforin activity were increased, it could help to increase the body’s ability to fight off cancers and certain viral diseases.
Research into perforin protein which plays a part in type 1 diabetes
Mon, 01 Nov 2010
Your comments may be moderated. Please report any spam, illegal, offensive or libellous posts.
Also related to this storyType 1 diabetes
Diabetes news and research forums
The Diet Plate
Diabetes and pensions
Guides for Indian Diabetics
Diabetes and alcohol
The cell interaction that kills insulin making cells in type 1 diabetes
1 Campaign raises issues of type 1 diabetes
Could taking leptin plus insulin help type 1 diabetics better control blood glucose
T cell in treatment role for children with type 1 diabetes
New cell therapy research in type 1 diabetes
Environmental and genetic factors could both be responsible for type 1 diabetes
Nanoparticle vaccine for type 1 diabetes developed
People with type 1 diabetes for many years retain active insulin-producing cells, study shows
Type 1 diabetes management can leave teens feeling stressed out
New Nanovaccine could reverse type 1 diabetes
Origins of type 1 diabetes one step closer due to discovery
Artificial pancreas brings hope to children with type 1 diabetes
Better type 1 diabetes treatment on the horizon
Cardiovascular Risk linked with insulin resistance in type 1 diabetes
New type 1 diabetes drug
Early type 1 diabetes detection markers identified
Type 1 diabetes prediction
Amongst type 1 diabetes patient intensive control halves complications
Type 1 diabetes children often overweight
Type 1 diabetes cases will double
Type 1 diabetes and sexual dysfunction
Many type 1 diabetes cases are misdiagnosed
Stem cells to delay type 1 diabetes onset
Multimedia support for type 1 diabetes children